Home » Trials » SLCTR/2012/011


Influence of long term ingestion of Scoparia dulcis (Wal kottamalli) porridge on glycaemic and lipid parameters

-

SLCTR Registration Number

SLCTR/2012/011


Date of Registration

23 Nov 2012

The date of last modification

Mar 03, 2019


Trial Status



Application Summary


Scientific Title of Trial

Influence of long term ingestion of Scoparia dulcis (Wal kottamalli) porridge on glycaemic and lipid parameters


Public Title of Trial

Influence of long term ingestion of Scoparia dulcis (Sinhala: Walkottamalli) porridge on glycaemic and lipid parameters


Disease or Health Condition(s) Studied

Diabetes mellitus type II


Scientific Acronym

None


Public Acronym

None


Brief title

None


Universal Trial Number

None


Any other number(s) assigned to the trial and issuing authority

632/12/01 (Ethics Review Committee, Faculty of Medical Sciences, University of Sri Jayawardenepura)


Trial Details


What is the research question being addressed?

Does the long term consumption of Scoparia dulcis (Wal koththamalli) green leafy porridge have any effect on diabetic parameters in patients with type II diabetes?


Type of study

Interventional


Study design

Allocation

Randomized controlled trial


Masking

Masking not used


Control

Standard therapy/practice


Assignment

Crossover


Purpose

Treatment


Study Phase

Not Applicable


Intervention(s) planned

Does the long term consumption of Scoparia dulcis (Wal koththamalli) green leafy porridge have any effect on diabetic parameters in patients with type II diabetes?


Inclusion criteria

•Patients with Type II diabetes •35-65 years • mild to moderate diabetes (FBG 126 – 200 mg/dL) • not currently consuming Scoparia dulcis extract/ porridge • ability to speak Sinhala or English


Exclusion criteria

• Type I diabetes • Macro vascular complications (stroke or myocardial infarction or both at least once in their life, recommended bypass surgeries (CABG), non-healing wounds, gangrene or amputated limbs/ toes; •Micro vascular complications (confirmed diabetic retinopathy confirmed diabetic nephropathy, elevated arterial blood pressure, confirmed kidney failure, confirmed diabetic neuropathy, • patients who refuse consent • current users of Scoparia dulcis extract/ porridge • patients who speak only Tamil



Primary outcome(s)

1.

liver profile, serum creatinine, lipid profile, serum ferritin, serum cortisol, HbA1c, fasting blood glucose

[

At baseline and monthly for 3 months

]

Secondary outcome(s)

1.

None

[

None

]

Target number/sample size

70


Countries of recruitment

Sri Lanka


Anticipated start date

2012-11-23


Anticipated end date

2013-03-15


Date of first enrollment

2012-12-15


Date of study completion


Recruitment status

Recruiting


Funding source

University grant of Sri Jayewardenepura, World Class University Project grant


Regulatory approvals



State of Ethics Review Approval


Status

Approved


Date of Approval

2012-08-30


Approval number

632/12


Details of Ethics Review Committee

Name: Ethics Review Committee, Faculty of Medical Sciences, University of Sri Jayewardenepura
Institutional Address:Gangodawila, Nugegoda Sri Lanka
Telephone:+94-112758000 (Extension: 4075)
Email: erc.fms.usjp@gmail.com

Contact & Sponsor Information


Contact person for Scientific Queries/Principal Investigator

Prof. Sagarika Ekanayake
Professor in Biochemistry
Dept. of Biochemistry, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda
011-2803578, 011-2801480
0716875891

sagarikae@hotmail.com

Contact Person for Public Queries

Prof. Sagarika Ekanayake
Professor in Biochemistry
Dept. of Biochemistry, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda
011-2803578, 011-2801480
0716875891

sagarikae@hotmail.com


Primary study sponsor/organization

Dept. of Biochemistry

Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda
011-2803578 011-2801480

biochemistry.fms@yahoo.com

Secondary study sponsor (If any)

None





Trial Completion details


Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?


IPD sharing plan description


Study protocol available


Protocol version and date

Not Available


Protocol URL

Not Available


Results summary available

No


Date of posting results


Date of study completion


Final sample size


Date of first publication


Link to results


Brief summary of results